Fundraising Fox
Protara Therapeutics
NASDAQ: TARAFounded 2017 · 66 employees on LinkedIn · 1 known investors
Find your way into Protara Therapeutics
Sign up to see every warm intro you have to Protara Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Protara Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Protara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.
Founders & leadership
JS
Jesse SheffermanChief Executive OfficerCo-founder and CEO of Protara Therapeutics, Jesse Shefferman previously held business development and strategy roles at Retrophin and Vertex Pharmaceuticals, and worked as an investment banker at Barclays Capital and Lehman Brothers advising biopharmaceutical companies. He holds an MBA and Certificate in Health Sector Management from Duke University and a BA in Accounting from Gordon College.
WC
William ConklingChief Commercial Officer
LN
Leonardo NicacioChief Medical Officer
Investors · 1
Frequently asked questions
- What does Protara Therapeutics do?
- Protara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.
- Who are Protara Therapeutics's investors?
- Protara Therapeutics's investors include Catalio Capital Management, LP.